Rate My Professor Ajay Velayudhan

Dr. Ajay Velayudhan is a consultant psychiatrist with over 20 years of experience in mental health services in Western Australia. For the last eight years, he has led a large and complex mental health service. He serves as a supervisor and examiner for psychiatric trainees and as a supervisor and assessor for overseas-trained psychiatrists seeking Fellowship of the Royal Australian and New Zealand College of Psychiatrists (FRANZCP) qualifications. His clinical expertise spans general adult psychiatry, encompassing mood disorders, psychotic conditions, anxiety disorders, post-traumatic stress disorder, personality disorders, and substance use disorders. Velayudhan is affiliated with the Fremantle Hospital Mental Health Service within the Fiona Stanley Fremantle Hospitals Group and contributes to the Western Australia Branch Committee of the RANZCP. He is also available for medical legal assessments in Perth.

Velayudhan has contributed significantly to research on mental health service delivery and integrated physical health care for patients with severe mental illness. His publications include longitudinal analyses of Assertive Community Treatment (ACT) programs, such as 'Longitudinal record linked analysis of an assertive community treatment programme in a suburban mental health hospital: emergency department presentations, hospital admissions and bed days' (2025) and 'Assertive Community Treatment - FHMHS 1992-2019' (2021), evaluating their impact on reducing hospital utilization. He has developed and evaluated the Wellness Clinic model, detailed in 'The Wellness Clinic: A retrospective Quasi-experimental, longitudinal study of physical health support in an Australian mental health service setting' (2020), 'The physical health Wellness Clinic model of care for patients with mental health issues who are hard to engage' (2019), and 'The Wellness Clinic: A model of integrated care to address the physical health of people with severe mental illness' (2019). Other works cover clozapine therapy, including 'Demographic and clinical characteristics of patients who recommence clozapine following therapy interruptions' (2022), and earlier psychobiological studies on platelet serotonin receptors in mania (1999), the psychobiology of social phobia (1997), betel nut abuse, and the social costs of alcoholism (2000).